speb/financial-data huggingface dataset:
4478.T — Peter Lynch category analysis (annual, as of 2025-06-30)
Sector: Technology | Industry: Software - Application
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 1576991923.6437862
Net income (USD): 9479822.861887628
Revenue growth %: 45.46625994270848
Smoothed growth %: 45.46625994270848
P/E ratio: 166.35246740568047
P/B ratio: 11.590480388547569
Pays dividend: no
Net asset value (USD): 107576944.36756158
Net cash (USD): 26399100.47052312
Net cash to market cap %: 1.674016212430914
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.938957442088045 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4480.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category:  (confidence: Low)
Market cap (USD): 619999034.6411482
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4480.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 888356986.0066206
Net income (USD): 7681312.067408969
P/E ratio: 115.6517243682664
P/B ratio: 7.784837195411393
Pays dividend: no
Net asset value (USD): 92973216.97261512
Net cash (USD): 58531447.48721036
Net cash to market cap %: 6.588730477634151
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 12.239156759307098 (Safe Zone)
Piotroski F-score: 4 (Weak)
4480.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 934752078.0598176
Net income (USD): 18178604.25652266
EPS growth %: 136.66014473819703
Revenue growth %: 36.03501432607483
Smoothed growth %: 136.66014473819703
P/E ratio: 51.420453675612606
P/B ratio: 7.496143479246994
PEG ratio: 0.37626517792820974
Pays dividend: no
Net asset value (USD): 101477762.8508803
Net cash (USD): 53454005.51509581
Net cash to market cap %: 5.718522244534141
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 12.138651438981617 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4480.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 729879327.9913853
Net income (USD): 17822791.260589845
EPS growth %: -1.9573174645965714
Revenue growth %: 28.56879109452497
EPS 2-year CAGR %: 52.3246383201013
Smoothed growth %: 52.3246383201013
P/E ratio: 40.952021337157824
P/B ratio: 5.66741298354771
PEG ratio: 0.7826527359182048
Pays dividend: no
Net asset value (USD): 20243327.600484107
Net cash (USD): -38136187.018281415
Net cash to market cap %: -5.224998921839793
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.166728432854759 (Safe Zone)
Piotroski F-score: 3 (Weak)
4480.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 370555281.3247235
Net income (USD): 6233616.776420945
EPS growth %: -65.02446398390549
Revenue growth %: 26.0064498949322
EPS 2-year CAGR %: -41.441521757037414
Smoothed growth %: -65.02446398390549
P/E ratio: 0.49566948481161033
P/B ratio: 4.797606185013325
Pays dividend: no
Net asset value (USD): -54056645.99450163
Net cash (USD): -114302154.59369606
Net cash to market cap %: -30.846181488783387
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.731554977096022 (Grey Zone)
Piotroski F-score: 5 (Neutral)
4483.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 3562706401.475168
Net income (USD): 26610391.739059173
P/E ratio: 133.88402682722514
P/B ratio: 13.949027277651213
Pays dividend: no
Net asset value (USD): 53056875.92198001
Net cash (USD): -124037043.10768728
Net cash to market cap %: -3.4815398500513175
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 9.54399047528146 (Safe Zone)
Piotroski F-score: 3 (Weak)
4483.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 2202392511.401802
Net income (USD): 32087087.08708709
EPS growth %: 20.581039925049787
Revenue growth %: 16.782255575461786
Smoothed growth %: 20.581039925049787
P/E ratio: 68.63796970489472
P/B ratio: 4.546434444304069
PEG ratio: 3.335009793229808
Pays dividend: no
Net asset value (USD): 141088588.5885886
Net cash (USD): -59459459.459459454
Net cash to market cap %: -2.69976669243277
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.156947146759592 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4483.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1541605092.6497622
Net income (USD): 30553354.463814054
EPS growth %: -4.779906069723176
Revenue growth %: -3.305426380621404
EPS 2-year CAGR %: 7.152871860131227
Smoothed growth %: 7.152871860131227
P/E ratio: 50.45616495156256
P/B ratio: 3.302785208257364
PEG ratio: 7.05397299688756
Pays dividend: no
Net asset value (USD): 58425779.18647649
Net cash (USD): -222358689.91019547
Net cash to market cap %: -14.423842459419872
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 3.3698621209864585 (Safe Zone)
Piotroski F-score: 3 (Weak)
4483.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 1200635274.3633204
Net income (USD): 49338323.75350889
EPS growth %: 61.48251024921948
Revenue growth %: 38.131337930135636
EPS 2-year CAGR %: 24.001531418073906
Smoothed growth %: 24.001531418073906
P/E ratio: 24.334739874050396
P/B ratio: 2.289124558779739
PEG ratio: 1.013882799816914
Pays dividend: no
Net asset value (USD): 92347279.7754311
Net cash (USD): -202553134.60767278
Net cash to market cap %: -16.870496722252625
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.7006314457289564 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4483.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1310169971.5715716
Net income (USD): 42617617.617617615
EPS growth %: -13.621675048117751
Revenue growth %: 13.21488246791445
EPS 2-year CAGR %: 18.104143637523308
Smoothed growth %: 18.104143637523308
P/E ratio: 0.1979518581081081
P/B ratio: 2.518772351334014
PEG ratio: 0.010934063608389952
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 94444444.44444445
Net cash (USD): -272309809.8098098
Net cash to market cap %: -20.784311632724222
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.734594577892505 (Grey Zone)
Piotroski F-score: 5 (Neutral)
4491.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 22359293.177615914
P/B ratio: 0.9790980652717756
Pays dividend: no
Net asset value (USD): 22751933.043843675
Net cash (USD): 10037911.472194986
Net cash to market cap %: 44.89368868888945
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4491.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 23356988.70471862
P/B ratio: 0.9761156482783142
Pays dividend: no
Net asset value (USD): 23863741.478411976
Net cash (USD): 11674883.037027135
Net cash to market cap %: 49.984538609074015
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4491.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Market cap (USD): 35705326.509825625
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4491.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 36176345.98654105
P/B ratio: 1.3984800898223062
Pays dividend: no
Net asset value (USD): 25819286.6756393
Net cash (USD): 11898694.48183042
Net cash to market cap %: 32.890813478666914
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4491.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 39328925.725725725
P/E ratio: 0.07239837798933052
P/B ratio: 1.4266576865903575
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 25939520.77077077
Net cash (USD): 12298023.023023022
Net cash to market cap %: 31.269664238447977
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4516.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 1680260125.3108978
P/B ratio: 1.019798260114304
Pays dividend: no
Net asset value (USD): 1441770556.100294
Net cash (USD): 229219778.68048745
Net cash to market cap %: 13.64192217785773
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4516.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 1661769408.966181
P/B ratio: 1.0052354823522374
Pays dividend: no
Net asset value (USD): 1328111215.078198
Net cash (USD): 148288998.79695228
Net cash to market cap %: 8.923560513080195
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4516.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 1423571794.0741765
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4516.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 1494295831.6991925
P/B ratio: 0.8533582898063102
Pays dividend: no
Net asset value (USD): 1431635262.449529
Net cash (USD): 212860026.91790038
Net cash to market cap %: 14.244838431748361
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4516.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: High)
Market cap (USD): 1714540601.4014013
P/E ratio: 0.07250938035687332
P/B ratio: 1.1807384476494591
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 1522197197.1971972
Net cash (USD): 153378378.3783784
Net cash to market cap %: 8.945741982022044
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
4523.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 10044838395.37043
P/B ratio: 1.6986414276183284
Pays dividend: no
Net asset value (USD): 3636657795.209413
Net cash (USD): -1456429471.914834
Net cash to market cap %: -14.49928226407394
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
4523.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 7572194755.3762865
P/B ratio: 1.308306749555873
Pays dividend: no
Net asset value (USD): 3560439780.777971
Net cash (USD): -1701176313.3270955
Net cash to market cap %: -22.46609296623352
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
4523.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 7845094700.247508
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4523.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 9296637550.359287
P/B ratio: 1.5702726504776696
Pays dividend: no
Net asset value (USD): 3625834454.912517
Net cash (USD): -1723445491.2516825
Net cash to market cap %: -18.538374567319522
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4523.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 8221288655.055055
P/E ratio: 0.2226183375281191
P/B ratio: 1.4860419534451095
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 3451370120.12012
Net cash (USD): -1737205955.9559557
Net cash to market cap %: -21.130579752698424
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 3 (Weak)
4530.T — Peter Lynch category analysis (quarterly, as of 2025-05-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 2957471988.426763
Dividend yield: 0.01
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
4534.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 984686468.4588593
Net income (USD): 86616948.04130471
P/E ratio: 11.368288663198978
P/B ratio: 0.933991300586507
Pays dividend: no
Net asset value (USD): 1048434682.8388789
Net cash (USD): 224700868.71004754
Net cash to market cap %: 22.819534532827355
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.774158246833568 (Safe Zone)
Piotroski F-score: 2 (Weak)
4534.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 826425452.5885135
Net income (USD): 49917417.41741742
EPS growth %: -42.36991888283401
Revenue growth %: -14.145256311957773
Smoothed growth %: -42.36991888283401
P/E ratio: 16.55585355463829
P/B ratio: 0.868322673477712
Pays dividend: no
Net asset value (USD): 945765765.7657659
Net cash (USD): 213596096.0960961
Net cash to market cap %: 25.845779002458674
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.616436253883242 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4534.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 714363063.2246433
Net income (USD): 30025092.445853144
EPS growth %: -39.85046903613117
Revenue growth %: -12.364643185406921
EPS 2-year CAGR %: -41.123669028995636
Smoothed growth %: -39.85046903613117
P/E ratio: 23.7922019561777
P/B ratio: 0.8454119665122494
Pays dividend: no
Net asset value (USD): 840227152.6677232
Net cash (USD): 105348652.93185422
Net cash to market cap %: 14.747214456513072
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.58978516009336 (Safe Zone)
Piotroski F-score: 3 (Weak)
4534.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 734248110.906296
Net income (USD): 37996257.18486833
EPS growth %: 26.54834370082383
Revenue growth %: 3.453535270836964
EPS 2-year CAGR %: -12.754234957454713
Smoothed growth %: 26.54834370082383
P/E ratio: 19.32422204992085
P/B ratio: 0.8405821455915773
Pays dividend: no
Net asset value (USD): 867350621.5746558
Net cash (USD): 145181125.51797885
Net cash to market cap %: 19.77276119087036
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.789535235630836 (Safe Zone)
Piotroski F-score: 8 (Strong)
4534.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 690087950.3503504
Net income (USD): 49443193.19319319
EPS growth %: 30.126483123404856
Revenue growth %: 4.102622839844565
EPS 2-year CAGR %: 28.324942668524457
Smoothed growth %: 28.324942668524457
P/E ratio: 0.09703535344560986
P/B ratio: 0.8717249367178814
PEG ratio: 0.003425791698192509
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 870889639.6396396
Net cash (USD): -70939689.6896897
Net cash to market cap %: -10.279804139990324
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 3.912908312508433 (Safe Zone)
Piotroski F-score: 3 (Weak)
4552.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Low)
Market cap (USD): 533582212.60260546
P/B ratio: 1.3354286370558643
Pays dividend: no
Net asset value (USD): 374387169.0712985
Net cash (USD): -205224821.40355796
Net cash to market cap %: -38.461705910800795
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4552.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Low)
Market cap (USD): 382083446.0072183
P/B ratio: 1.1976227676624627
Pays dividend: no
Net asset value (USD): 296611415.5861516
Net cash (USD): -293536960.2994252
Net cash to market cap %: -76.82535408610184
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4552.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Low)
Market cap (USD): 419266105.7964295
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4552.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Low)
Market cap (USD): 521609631.6117093
P/B ratio: 1.5976089052806233
Pays dividend: no
Net asset value (USD): 305847913.8627187
Net cash (USD): -302267833.10901755
Net cash to market cap %: -57.94905131928781
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4552.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: High)
Market cap (USD): 394661541.5415415
P/E ratio: 0.1991902216117463
P/B ratio: 1.4634084216305245
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 277414914.9149149
Net cash (USD): -299486986.986987
Net cash to market cap %: -75.8845125413527
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4554.T — Peter Lynch category analysis (annual, as of 2021-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 238337569.03903875
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4554.T — Peter Lynch category analysis (annual, as of 2022-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 168994473.8908814
Net income (USD): 18673405.802118674
P/E ratio: 9.050008106807564
P/B ratio: 0.6817270023199172
Pays dividend: no
Net asset value (USD): 175842968.91227582
Net cash (USD): -250564287.19795054
Net cash to market cap %: -148.2677400207407
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.6655242282847054 (Distress Zone)
Piotroski F-score: 2 (Weak)
4554.T — Peter Lynch category analysis (annual, as of 2023-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 190290871.63780636
Net income (USD): 23001205.303334672
EPS growth %: 23.176272968506733
Revenue growth %: 11.626070119050942
Smoothed growth %: 23.176272968506733
P/E ratio: 8.273082611467249
P/B ratio: 0.6901937817649488
PEG ratio: 0.356963460980512
Pays dividend: no
Net asset value (USD): 205430561.13566357
Net cash (USD): -280125887.2371769
Net cash to market cap %: -147.20931425988718
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.6231827239905707 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4554.T — Peter Lynch category analysis (annual, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 223823557.8057151
Net income (USD): 43052248.21403558
EPS growth %: 87.17387913490752
Revenue growth %: 18.021476810126337
EPS 2-year CAGR %: 51.83998428903915
Smoothed growth %: 51.83998428903915
P/E ratio: 5.198881988530991
P/B ratio: 0.7014228744650032
PEG ratio: 0.10028710578969491
Pays dividend: no
Net asset value (USD): 231923238.54881635
Net cash (USD): -279128729.51393753
Net cash to market cap %: -124.709272004437
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.708318367502269 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4554.T — Peter Lynch category analysis (annual, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 269269073.1569314
Net income (USD): 20188425.30282638
EPS growth %: -53.107152029647786
Revenue growth %: 7.618540306285791
EPS 2-year CAGR %: -6.313734953866912
Smoothed growth %: -53.107152029647786
P/E ratio: 13.337794757040001
P/B ratio: 0.8530728977959707
Pays dividend: no
Net asset value (USD): 221810228.80215344
Net cash (USD): -264165545.0874832
Net cash to market cap %: -98.10467351128965
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.0063054796533257 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4565.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 553624061.3688009
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4565.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 573161030.0442846
P/B ratio: 1.2576977583395335
Pays dividend: no
Net asset value (USD): -72820370.88292277
Net cash (USD): -316897315.2504843
Net cash to market cap %: -55.28940361245418
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4565.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 486261549.6314339
P/B ratio: 1.2468837644122264
Pays dividend: no
Net asset value (USD): -89962278.62668628
Net cash (USD): -341570232.0823477
Net cash to market cap %: -70.24413761302817
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4565.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 518225899.4994995
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4572.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 183927720.99173555
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4572.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 75056374.3605176
Net income (USD): -10153016.85224195
P/B ratio: 2.7394063393691934
Pays dividend: no
Net asset value (USD): 27384366.536262415
Net cash (USD): 20722539.873608187
Net cash to market cap %: 27.609300409411997
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 8.998911676821065 (Safe Zone)
Piotroski F-score: 2 (Weak)
4572.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 70811457.31457257
Net income (USD): -8151700.48787386
Revenue growth %: 10.189988024992038
Smoothed growth %: 10.189988024992038
P/B ratio: 2.5827914920174804
Pays dividend: no
Net asset value (USD): 27408923.142190482
Net cash (USD): 17087923.35430955
Net cash to market cap %: 24.131579835164555
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 11.988501532529268 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4572.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 36458283.39773231
Net income (USD): -13877164.150582839
Revenue growth %: -64.746989078556
Smoothed growth %: -64.746989078556
P/B ratio: 2.312229245033234
Pays dividend: no
Net asset value (USD): 15767590.29237531
Net cash (USD): 11540371.998216446
Net cash to market cap %: 31.653635121324044
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 7.260329934700668 (Safe Zone)
Piotroski F-score: 4 (Weak)
4572.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 43779634.536247686
Net income (USD): -13883191.611789528
Revenue growth %: -8.649436012015663
Smoothed growth %: -8.649436012015663
P/B ratio: 22.144806052087848
Pays dividend: no
Net asset value (USD): 1976970.7819193148
Net cash (USD): -2580659.8043603348
Net cash to market cap %: -5.894658170852609
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -1.9057638017737917 (Distress Zone)
Piotroski F-score: 3 (Weak)
457A.T — Peter Lynch category analysis (annual, as of 2023-08-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
457A.T — Peter Lynch category analysis (annual, as of 2024-08-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
457A.T — Peter Lynch category analysis (annual, as of 2025-08-31)
Sector: Consumer Cyclical | Industry: Personal Services
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4586.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 66104676.32883863
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4586.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 42429162.729461335
Net income (USD): -8359539.572675294
P/B ratio: 4.650476750025356
Pays dividend: no
Net asset value (USD): 9123615.708696961
Net cash (USD): 6082380.379175445
Net cash to market cap %: 14.33537686792969
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 14.329491866793106 (Safe Zone)
Piotroski F-score: 2 (Weak)
4586.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 63382095.72226543
Net income (USD): -6596174.7861132715
Revenue growth %: -53.33562009433048
Smoothed growth %: -53.33562009433048
P/B ratio: 4.657341622283841
Pays dividend: no
Net asset value (USD): 13609071.625539135
Net cash (USD): 11264929.64717528
Net cash to market cap %: 17.773046976132147
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 41.050999729703406 (Safe Zone)
Piotroski F-score: 4 (Weak)
4586.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 30835105.061126243
Net income (USD): -5138900.56691509
Revenue growth %: 686.7266867765646
Smoothed growth %: 686.7266867765646
P/B ratio: 2.2307869148018615
Pays dividend: no
Net asset value (USD): 13822523.727625962
Net cash (USD): 11924555.70418498
Net cash to market cap %: 38.67201256667111
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 27.020448188799584 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4586.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Speculative (confidence: Low)
Market cap (USD): 41096279.623101085
Net income (USD): -5993050.316475929
Revenue growth %: -50.15452321599062
Smoothed growth %: -50.15452321599062
P/B ratio: 3.137091491832191
Pays dividend: no
Net asset value (USD): 13100121.475608977
Net cash (USD): 10524429.384310465
Net cash to market cap %: 25.609202294785007
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 34.539145902026455 (Safe Zone)
Piotroski F-score: 3 (Weak)
458A.T — Peter Lynch category analysis (quarterly, as of 2025-05-31)
Sector: Real Estate | Industry: Real Estate Services
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
458A.T — Peter Lynch category analysis (quarterly, as of 2025-11-30)
Sector: Real Estate | Industry: Real Estate Services
Lynch category:  (confidence: High)
Market cap (USD): 25014458.152034808
P/E ratio: 0.0776541778070832
P/B ratio: 2.211124629241243
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 11311127.463527003
Net cash (USD): -36652450.72945994
Net cash to market cap %: -146.52506365195217
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4616.T — Peter Lynch category analysis (annual, as of 2021-11-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 23230898.708260108
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4616.T — Peter Lynch category analysis (annual, as of 2022-11-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 14821606.705348132
Net income (USD): 1169186.968430157
P/E ratio: 12.67684904600741
P/B ratio: 0.7565377193898986
Pays dividend: no
Net asset value (USD): 19434741.24261208
Net cash (USD): -23332896.06458123
Net cash to market cap %: -157.42487659021432
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.6474373488191696 (Distress Zone)
Piotroski F-score: 4 (Weak)
4616.T — Peter Lynch category analysis (annual, as of 2023-11-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 9865191.41084059
Net income (USD): 1380597.1164309033
EPS growth %: 18.081808445453532
Revenue growth %: 2.896618649730187
Smoothed growth %: 18.081808445453532
P/E ratio: 7.145597577622006
P/B ratio: 0.4747565289188308
PEG ratio: 0.3951815770628123
Pays dividend: no
Net asset value (USD): 20632093.30794342
Net cash (USD): -23024816.376496196
Net cash to market cap %: -233.39452239309674
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.6096347089388847 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4616.T — Peter Lynch category analysis (annual, as of 2024-11-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 9867824.790633062
Net income (USD): 1128398.491764239
EPS growth %: -18.267358497650925
Revenue growth %: -6.361170405088891
EPS 2-year CAGR %: -1.7597937826812737
Smoothed growth %: -18.267358497650925
P/E ratio: 8.74498225817798
P/B ratio: 0.46361349530953566
Pays dividend: no
Net asset value (USD): 21189515.11543296
Net cash (USD): -22027227.624528676
Net cash to market cap %: -223.22272731714702
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.558673467754777 (Distress Zone)
Piotroski F-score: 4 (Weak)
4616.T — Peter Lynch category analysis (annual, as of 2025-11-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 13879273.515485026
Net income (USD): 462746.35270028154
EPS growth %: -58.99087458218927
Revenue growth %: -2.9574856651253096
EPS 2-year CAGR %: -42.105404862813
Smoothed growth %: -58.99087458218927
P/E ratio: 29.99326398683592
P/B ratio: 0.6504368871191145
Pays dividend: no
Net asset value (USD): 21283401.586895317
Net cash (USD): -22077585.1036601
Net cash to market cap %: -159.0687371282673
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5820492165633557 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4619.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 119877846.38165875
Net income (USD): 16276020.324536962
P/E ratio: 7.3653045395216505
P/B ratio: 0.2941796515795507
Pays dividend: no
Net asset value (USD): 352401245.6974267
Net cash (USD): -173094574.6598918
Net cash to market cap %: -144.39246273144192
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.719793654791888 (Distress Zone)
Piotroski F-score: 3 (Weak)
4619.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 129142011.04647148
Net income (USD): 21231231.23123123
EPS growth %: 30.444855731864784
Revenue growth %: 1.5718080299398016
Smoothed growth %: 30.444855731864784
P/E ratio: 6.082643518879066
P/B ratio: 0.3294716696301475
PEG ratio: 0.19979216102879185
Pays dividend: no
Net asset value (USD): 337432432.4324325
Net cash (USD): -142289789.7897898
Net cash to market cap %: -110.18086882554982
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.8753326855300678 (Grey Zone)
Piotroski F-score: 8 (Strong)
4619.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 182444096.02568674
Net income (USD): 29860010.56524036
EPS growth %: 40.641916806577655
Revenue growth %: -6.317078069695219
EPS 2-year CAGR %: 35.447460469685254
Smoothed growth %: 35.447460469685254
P/E ratio: 6.109980960223353
P/B ratio: 0.46385182409351133
PEG ratio: 0.17236724096070638
Pays dividend: no
Net asset value (USD): 344433438.9857369
Net cash (USD): -79219492.86846276
Net cash to market cap %: -43.42124222935077
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.2729098786978232 (Grey Zone)
Piotroski F-score: 8 (Strong)
4619.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 197825457.47974867
Net income (USD): 36920197.834514104
EPS growth %: 23.644289253843777
Revenue growth %: 3.3551755131053183
EPS 2-year CAGR %: 31.869518247575023
Smoothed growth %: 31.869518247575023
P/E ratio: 5.358190613345402
P/B ratio: 0.4616637023399309
PEG ratio: 0.16812901192044566
Pays dividend: no
Net asset value (USD): 375384306.9108408
Net cash (USD): -32716214.409838244
Net cash to market cap %: -16.5379192479246
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.735470473788339 (Grey Zone)
Piotroski F-score: 8 (Strong)
4619.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Auto Parts
Lynch category: Cyclical (confidence: High)
Market cap (USD): 324497502.3023023
Net income (USD): 36223723.723723724
EPS growth %: -1.8864311451205023
Revenue growth %: -12.304143191026334
EPS 2-year CAGR %: 10.141647378362917
Smoothed growth %: 10.141647378362917
P/E ratio: 0.0561147829899377
P/B ratio: 0.6906558484378263
PEG ratio: 0.005533103340750924
Dividend yield: 0.06
Pays dividend: yes
Net asset value (USD): 369219219.2192192
Net cash (USD): -15872122.122122124
Net cash to market cap %: -4.89129253985309
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.5873196958018756 (Safe Zone)
Piotroski F-score: 8 (Strong)
4623.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 42876868.2248214
P/B ratio: 0.4337945374076941
Pays dividend: no
Net asset value (USD): 92655645.04832609
Net cash (USD): -24419015.268244848
Net cash to market cap %: -56.9514898807574
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4623.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 42269192.71888784
P/B ratio: 0.4469101753822625
Pays dividend: no
Net asset value (USD): 89182134.74134474
Net cash (USD): -27051430.29006817
Net cash to market cap %: -63.99798186346798
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4623.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 42422719.93274287
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4623.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 42492465.78358008
P/B ratio: 0.42470707405687785
Pays dividend: no
Net asset value (USD): 95142994.61641993
Net cash (USD): -27309313.593539707
Net cash to market cap %: -64.26860171548944
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4623.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 39872723.923923925
P/E ratio: 0.05481514319576568
P/B ratio: 0.4253408292105764
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 89707057.05705705
Net cash (USD): -41846365.11511511
Net cash to market cap %: -104.9498529244123
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4627.T — Peter Lynch category analysis (annual, as of 2021-10-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 93725469.53309277
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4627.T — Peter Lynch category analysis (annual, as of 2022-10-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 69665482.00527705
Net income (USD): 10244455.720181314
P/E ratio: 6.800310715193764
P/B ratio: 0.46624896957317435
Pays dividend: no
Net asset value (USD): 146742216.35883904
Net cash (USD): 22022894.256139636
Net cash to market cap %: 31.61234749581067
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.3354500245650893 (Safe Zone)
Piotroski F-score: 4 (Weak)
4627.T — Peter Lynch category analysis (annual, as of 2023-10-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 65290936.072966255
Net income (USD): 6379243.511501576
EPS growth %: -37.72979565000579
Revenue growth %: -2.2376266779000185
Smoothed growth %: -37.72979565000579
P/E ratio: 10.234902611140138
P/B ratio: 0.42787366649870556
Pays dividend: no
Net asset value (USD): 150179055.73066863
Net cash (USD): 28065890.95298773
Net cash to market cap %: 42.9858915204134
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.2362569727588966 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4627.T — Peter Lynch category analysis (annual, as of 2024-10-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 65323434.230483025
Net income (USD): 6240045.691906006
EPS growth %: -2.1820427350766662
Revenue growth %: 0.1735509521143179
EPS 2-year CAGR %: -21.954217359387208
Smoothed growth %: -2.1820427350766662
P/E ratio: 10.468422421203481
P/B ratio: 0.4245406975893081
Pays dividend: no
Net asset value (USD): 151443139.68668407
Net cash (USD): 35874993.47258486
Net cash to market cap %: 54.91902545418207
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.245983476994763 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4627.T — Peter Lynch category analysis (annual, as of 2025-10-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 76173516.7748538
Net income (USD): 7392956.465237167
EPS growth %: 18.475998898960096
Revenue growth %: 6.845366751074638
EPS 2-year CAGR %: 7.652590294974249
Smoothed growth %: 7.652590294974249
P/E ratio: 10.303525677857504
P/B ratio: 0.47684079457939793
PEG ratio: 1.3464102063093888
Pays dividend: no
Net asset value (USD): 156459662.1182586
Net cash (USD): 34235828.46003898
Net cash to market cap %: 44.9445291612699
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.3776234065881146 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4629.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 42057790.41910632
P/B ratio: 0.3738300831264562
Pays dividend: no
Net asset value (USD): 112029815.10015409
Net cash (USD): -18161416.164728954
Net cash to market cap %: -43.182050183212795
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4629.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 41771653.449271485
P/B ratio: 0.3783176192630843
Pays dividend: no
Net asset value (USD): 110007265.0715145
Net cash (USD): -10363126.587354638
Net cash to market cap %: -24.80899301709441
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4629.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 47879170.321062826
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4629.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 49388512.30982503
P/B ratio: 0.436358429180916
Pays dividend: no
Net asset value (USD): 111756830.41722746
Net cash (USD): -9479724.09152086
Net cash to market cap %: -19.194188381404285
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4629.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 54699467.467467465
P/E ratio: 0.057943201755910785
P/B ratio: 0.4732906091339196
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 106619112.86286286
Net cash (USD): 4065703.2032032013
Net cash to market cap %: 7.432802166897293
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4635.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 38450882.23340436
Net income (USD): 5941648.910014752
P/E ratio: 6.471416069131034
P/B ratio: 0.1826446842930551
Pays dividend: no
Net asset value (USD): 204564825.43845272
Net cash (USD): -147492214.39108345
Net cash to market cap %: -383.586034504428
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.904592310086993 (Grey Zone)
Piotroski F-score: 3 (Weak)